← All reportsEN한국어

CEG — Research Report (2026-07-24)

TL;DR


1. Business overview

So what: CEG doesn't sell a product to consumers — it sells electricity (and increasingly, long-term promises of electricity) to utilities, grid operators, and now directly to tech companies.

Constellation Energy Corporation was spun off from Exelon in 2022. It owns and operates the largest fleet of nuclear power plants in the United States (~21 reactors before Calpine), plus hydro, wind, solar, and — since January 2026 — a large natural gas fleet inherited from Calpine. It sells electricity three ways:

  1. Wholesale/merchant power — sold into competitive markets like PJM (the mid-Atlantic/Midwest grid).
  2. Long-term bilateral contracts (PPAs — Power Purchase Agreements, fixed-price supply deals) — increasingly with AI data-center operators.
  3. Retail supply — competitive electricity/gas supply to businesses and some residential customers.

Geography: concentrated in PJM territory (mid-Atlantic, Midwest, Texas via Calpine's gas fleet), the largest wholesale power market in the US.

The 2026 turning point: Calpine acquisition + hyperscaler PPAs

Customer concentration: improving on paper (multiple hyperscalers + wholesale markets + Calpine's gas customer base), but the growth story is now concentrated in a handful of 20-year contracts with 2-3 tech giants — a structural bet on their AI capex continuing.


2. Financials (5-year, EDGAR US-GAAP)

So what: Revenue doubled in one year purely from consolidating Calpine — organic growth is much slower; cash flow only recently turned reliably positive.

Fiscal Year Revenue ($M) Operating Income ($M) Net Income ($M) OCF ($M) Capex ($M) FCF ($M)
2021 19,649 (346) (205) (1,338) 1,329 (2,667)
2022 24,440 495 (160) (2,353) 1,689 (4,042)
2023 24,918 1,610 1,623 (5,301) 2,422 (7,723)
2024 23,568 4,352 3,749 (2,464) 2,565 (5,029)
2025 25,533 3,086 2,319 4,237 2,949 1,288

FCF = OCF − Capex. Note: 2021-2024 negative OCF is driven largely by nuclear decommissioning trust and hedging/collateral swings typical of merchant power accounting, not core operating losses — but it means 2025 is the first year CEG generated real free cash flow in this dataset.

Balance Sheet 2021 2022 2023 2024 2025
Total Assets ($M) 48,086 46,909 50,758 52,926 57,249
Total Liabilities ($M) 36,472 35,537 39,472 39,387 42,396
Stockholders' Equity ($M) 11,219 11,018 10,925 13,166 14,517
Cash ($M) 504 422 368 3,022 3,641
LT Debt ($M) 4,575 4,466 7,496 7,384 7,250
Net Debt ($M, LT debt − cash) 4,071 4,044 7,128 4,362 3,609

Important caveat: this 2025 fiscal-year-end balance sheet predates the Calpine close (Jan 7, 2026). Post-close, CEG raised new bonds and repaid ~$3.75B of Calpine debt — meaning the real, current net debt picture is materially larger than the $3.6B shown above. Treat 2025 net debt as the "before Calpine" baseline, not the current state.

Revenue CAGR 2020-2025: ~8%/yr nominal — but the 2025 jump (+8.3% YoY) is almost entirely Calpine-adjacent contract wins and PJM capacity price increases, not organic volume growth.


3. Metrics table with the why

So what: Every ratio here says the same thing from a different angle — this is a high-quality, improving balance sheet trading at a price that has already given the company credit for future growth.

Metric Value Why this matters here
P/E (TTM) ~37× (at $276/sh, 2025 EPS) Price per $1 of last year's earnings — very rich for a "utility," priced like a growth tech stock because the market is pricing in the AI-PPA pipeline, not 2025's actual earnings
Revenue CAGR (5y) ~8% Real, but the recent jump is M&A/price, not organic demand growth — don't confuse the two
OCF trend Negative → +$4.24B in 2025 Cash conversion just turned the corner; 2025 is the first "prove it" year of real cash generation
FCF (2025) +$1.29B The anti-story metric — actual spendable cash left after capex, positive for the first time in this dataset
Net debt / EBITDA Understated pre-Calpine; expect meaningfully higher post-close Calpine added real leverage — CEG's balance sheet is now a levered, capital-heavy story, not a pristine utility one
Capex (2025) $2.95B, rising Nuclear uprates + Calpine gas fleet maintenance — the capex line predicts whether 2027-2029 capacity actually shows up
Backlog vs. market cap 5,650+ MW of 20-year PPAs vs. $86B market cap How much of the AI story is already contracted, not speculative — this is the single most important number in the bull case

4. Ownership & management

So what: Ownership is boring in the reassuring way — heavily institutional, no controlling family or founder, CEO stake is small but that's normal for a former utility spinoff.


5. Market, value chain position, and competitors

So what: CEG sits in the best possible seat in the AI power story — the bottleneck — but "bottleneck" doesn't mean "monopoly"; gas, other nuclear owners, and even hyperscalers building their own power are all real alternatives.

Value chain position: bottleneck, with real but limited pricing power. New firm (always-available) carbon-free power is scarce and slow to build (a new reactor takes a decade-plus; even a restart like Crane/Three Mile Island takes years). That scarcity is why Microsoft and Meta signed 20-year deals rather than shopping around further — CEG could ask, and got, premium fixed pricing. But CEG is not a monopoly: hyperscalers can also contract gas peaker capacity (Calpine's own fleet, or NRG's), build on-site generation, or fund new nuclear (SMRs) directly — all of which cap how far CEG's pricing power can run.

Named competitors:

Who has pricing power over CEG: fuel-cost pass-through is limited for nuclear (fuel is a small % of nuclear opex, unlike gas), so CEG is relatively insulated from commodity swings on its legacy nuclear fleet — but the newly acquired Calpine gas fleet reintroduces natural-gas price exposure that CEG didn't have before.


6. Valuation — what's the multiple, and what would a buyer pay?

So what: CEG trades at a real premium to the utility/IPP sector on every profitability multiple — which is either fully justified by 20-year locked-in contracts, or a sign the market has front-run execution risk.

CEG is profitable, so P/E is the primary lens; EV/EBITDA is the useful cross-check because CEG just took on significant new debt (capital-heavy story post-Calpine).

Metric CEG Sector typical range Source
P/E (TTM) ~37× (at ~$276/sh) Regulated utilities ~16-20×; merchant/IPP peers more variable, often 15-25× in normal periods stockanalysis.com CEG (note: cached price data was inconsistent across sources — see caveat below)
EV/EBITDA (recent M&A comps in the space) Not cleanly computable from the EDGAR tags provided (no D&A series pulled) IPP asset-deal multiples running ~7-8× 2026 EBITDA (NRG/LS Power at 7.5×, Vistra/Lotus at 7×); public IPP peers trading multiple has re-rated to ~8× EV/EBITDA after 2025-2026 pullbacks AdvisorAnalyst IPP sector note
Consensus 12-month price target ~$358-380 (wide range $272-441 across firms) tickernerd.com, UBS PT raise

Data-quality caveat (be transparent, not falsely precise): search results returned materially different "current" CEG prices across sources in this session ($239, $276, $388) — a sign of stale-cache aggregator noise, not a real intraday move of that size. The most internally consistent, dated data point is ~$276 as of 2026-07-01 (Motley Fool, sourced from the Citi-downgrade article), against a confirmed 52-week range of $228.63-$412.70. This report uses ~$276 and ~312M shares (2025 10-K) → market cap ≈ $86B. Treat the exact current price as approximate; verify live before any real decision.

What a reasonable buyer might pay: if you believe the 5,650+ MW of signed 20-year PPAs de-risk the growth case the way management claims, a premium to the ~8× sector EV/EBITDA (something like 10-12×, similar to what a strategic buyer might pay for contracted, investment-grade counterparty cash flows) is defensible. If you think the PPA economics or Calpine integration disappoint, reversion toward the 7-8× deal-multiple range implies real downside from here — which is exactly Goldman's and Citi's argument.


7. Bull / base / bear — attributed to named institutions

So what: Nobody disputes CEG is a good business — the entire debate on Wall Street right now is "is it already in the price?"

Bull case — UBS (price target raised to $385, Buy): (TipRanks) UBS raised its target after continued confidence in the AI-power demand pipeline and contract execution. Companion view: Morgan Stanley, Overweight, price target raised to $364 the week before the Citi cut — "maintained a bullish stance" even as sentiment wobbled. (Yahoo Finance/CA)

Base case — Goldman Sachs (Neutral, $305 PT), initiated coverage: "high-quality beneficiary of rising power demand," but "much of the opportunity is already reflected in the stock's valuation." (Insider Monkey/Goldman) This is a "great company, full price" call, not a fundamental doubt.

Bear case — Citi (price target cut from $348 to $297, Neutral) and Seaport Research (downgraded to Neutral from Buy): (Fool.com, TipRanks/Seaport) Citi's own framing: "strong earnings and marquee contracts unable to offset a valuation reset" — i.e., investors wanted proof AI demand converts to faster profit growth, not just headline contract announcements, and stopped paying up while waiting. No institution reviewed here argues the business is deteriorating — the entire bear case is valuation, not fundamentals.

Catalysts (bull): Calpine integration synergies land faster than guided; new hyperscaler PPAs announced; PJM capacity auction prices stay elevated; nuclear uprate capacity comes online on schedule.

What would prove the thesis wrong: Calpine integration costs run over guidance; a hyperscaler PPA counterparty scales back AI capex (the single biggest tail risk — CEG's growth case is now a bet on 2-3 companies' capex staying enormous); a natural gas price spike hits the newly-acquired Calpine fleet's margins; regulatory pushback on nuclear-restart subsidies or PPA structures.


8. PE/quality lens

So what: A private-equity buyer would love the contracted cash flows and hate the price they'd have to pay to get in today.

What a buyer would love: 20-year, investment-grade counterparty (Microsoft, Meta) revenue contracts; a scarce, hard-to-replicate nuclear fleet; first positive free cash flow year; large scale post-Calpine (55 GW, #1 US power producer).

What a buyer would fear: paying a growth-stock multiple for a capital-intensive, historically-cyclical merchant power business; integration risk on a $22B acquisition closed only months ago; leverage that's understated in the FY2025 balance sheet (pre-Calpine-close) and materially higher today; concentration risk in a handful of AI-capex-dependent contracts.


9. Practitioner decision layer

9a. Reverse expectations (multiple-and-consensus approximation, not a DCF)

At ~37× trailing P/E against consensus 2026 EPS guidance of $11.00-$12.00 (reaffirmed at Q1 2026 — TIKR), a ~$276 share price implies roughly a 23-25× forward P/E on guided 2026 EPS. For a capital-intensive power generator, a forward multiple in the low-to-mid 20s is only justified by sustained double-digit EPS growth for several years — consistent with management's own framing of Calpine + nuclear uprates driving free cash flow from ~$8.4B (2026-2027) toward $11.5-13.0B by 2028-2029 (TIKR).

Judgment: plausible, not implausible — but stretched. The FCF ramp to 2028-2029 is management's own guide, not yet proven, and depends on nuclear uprates and Calpine synergies landing on schedule. Base rate for large-cap utility M&A integrations delivering exactly as promised is mixed-to-poor historically; the multiple leaves little room for a stumble.

9b. Variant perception

  1. Consensus believes: CEG is the best-positioned pure play on AI-driven electricity demand, with de-risked growth from signed 20-year PPAs.
  2. This report's differentiated view: Consensus agreement — no strongly differentiated view supported by the evidence gathered here.
  3. Evidence: Every major bank view found (UBS, Morgan Stanley, Goldman, Citi, Seaport) agrees the business is high quality; they diverge only on whether the price already reflects it, which is itself the consensus debate, not a contrarian one.
  4. Why the market may be wrong: No unique edge found in this research pass beyond what's already public and priced — this report does not manufacture a contrarian angle where the evidence doesn't support one.

9c. Probability-weighted expected value

Scenario Probability Target price Key condition Source/assumption
Bull 30% $385 Calpine synergies + hyperscaler capex both land on/ahead of schedule UBS PT (TipRanks)
Base 45% $340 Guidance met, no major surprises, multiple stays rich but doesn't expand Blends Morgan Stanley $364 / consensus mean ~$358-372
Bear 25% $297 Valuation resets further even without a fundamental miss (Citi's actual thesis) Citi PT (Fool.com)

EV = 0.30×385 + 0.45×340 + 0.25×297 = $115.5 + $153.0 + $74.25 = ~$342.75, roughly 24% above the ~$276 reference price used in this report — but this reflects the fact that most published targets sit above the current depressed price after the recent selloff; it is a scenario exercise, not a forecast, and is highly sensitive to which price point is treated as "current" given the data inconsistency flagged in §7.

9d. Pre-mortem: stock is down 50% in two years — what happened?

  1. A major hyperscaler PPA counterparty pulls back AI capex (demand shock). Earliest signal: any of Microsoft/Meta/Amazon guiding down data-center capex on an earnings call. Invalidated if capex guides stay flat-to-up for 2+ more quarters.
  2. Calpine integration disappoints — cost overruns, gas-fleet margin compression from a gas price spike, or lower-than-guided synergies. Earliest signal: management walking back the ~$2/share Calpine accretion guide at a quarterly print. Invalidated by continued guidance reaffirmation with clean beats (as in Q1 2026).
  3. Multiple compression alone, even with fine fundamentals — the Goldman/Citi thesis playing out further. Earliest signal: continued sell-side PT cuts despite in-line-or-better earnings (already happening in mid-2026). Invalidated if the stock re-rates back toward the 30%+ analyst upside currently implied without needing a fundamental catalyst.

9e. KPI driver tree and sensitivity

Core drivers: (1) contracted MW under long-term PPA × fixed price, (2) merchant/wholesale power price realized in PJM, (3) Calpine gas-fleet spark spread (revenue minus fuel cost).

9f. Scuttlebutt proxies

9g. Decision and review contract

Decision (Educational — not investment advice)


📚 What this company teaches

  1. "Priced for perfection" risk is a real, distinct risk category — separate from the business being bad. Every analyst here agrees CEG is high-quality; the entire live debate is whether the price has already collected the reward before the risk has cleared. Learn to distinguish "I don't like this business" from "I like this business but not at this price."
  2. Contracted backlog (PPAs) is the power-sector equivalent of order backlog in industrials — it converts a speculative growth story into a scheduled one. A 20-year fixed-price deal with an investment-grade counterparty (Microsoft, Meta) is about as close to "locked-in revenue" as a public company can show you.
  3. A single acquisition can silently change a company's risk profile. Before Calpine, CEG was overwhelmingly a nuclear (fuel-cost-insulated) business. After Calpine, it's meaningfully exposed to natural gas prices — a new risk factor that didn't exist in the "old" CEG story, and easy to miss if you only look at revenue/EPS growth without asking what changed underneath it.

Self-test question: If PJM wholesale power prices fell 15% next year but CEG's 5,650+ MW of 20-year hyperscaler PPAs are fixed-price and unaffected, would you expect CEG's EPS to fall by roughly 15%, meaningfully less than 15%, or meaningfully more than 15% — and why does the answer depend on what % of CEG's total generation is contracted versus sold at merchant/spot prices?


📖 Glossary